Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans

Natalia S Pellegata1, Leticia Quintanilla-Martinez, Heide Siggelkow

  • 1Institutes of Pathology, GSF-National Research Center for Environment and Health, 85764 Neuherberg, Germany. natalia.pellegata@gsf.de

Insights

Multiple endocrine neoplasia-like syndrome (MENX) in rats is caused by a Cdkn1b mutation, leading to reduced p27(Kip1). A similar mutation in human CDKN1B predisposes to endocrine tumors, linking p27(Kip1) to multiple endocrine neoplasia.

Area of Science:

  • Endocrinology
  • Genetics
  • Oncology

Background:

  • Multiple endocrine neoplasia (MEN) syndromes involve tumors in endocrine glands.
  • MENX in rats shares tumor characteristics with human MEN types 1 and 2.
  • Previous mapping excluded known MEN-associated genes.

Purpose of the Study:

  • To fine-map the MenX locus in rats.
  • To identify the genetic cause of MENX.
  • To investigate the role of p27(Kip1) in endocrine tumorigenesis.

Main Methods:

  • Fine genetic mapping of the MenX locus on rat chromosome 4.
  • Mutation analysis of the Cdkn1b gene in affected rats.
  • Germline mutation screening of the human CDKN1B gene in MEN1-negative patients.

Main Results:

  • A homozygous frameshift mutation in rat Cdkn1b was identified in MENX rats, causing a p27(Kip1) protein reduction.
  • A germline nonsense mutation in human CDKN1B was found in a MEN1-negative patient with pituitary and parathyroid tumors.
  • Pedigree analysis confirmed the association of the human CDKN1B mutation with an MEN1-like phenotype.

Conclusions:

  • Germline mutations in p27(Kip1) are implicated in the development of multiple endocrine tumors.
  • Cdkn1b mutations can cause MENX in rats and contribute to MEN1-like syndromes in humans.
  • p27(Kip1) is a key factor in endocrine tumor predisposition.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...